FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.9.1  |  FHIR Version n/a  User: [n/a]

7386311000001102: Rhinolast 140micrograms/dose nasal spray (Viatris UK Healthcare Ltd) 22 ml (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
229391000001119 Rhinolast 140micrograms/dose nasal spray (Mylan) 22 ml en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
229401000001116 Rhinolast 140micrograms/dose nasal spray (Mylan) 22 ml (product) en Fully specified name Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
2140101000001118 Rhinolast 140micrograms/dose nasal spray (Viatris UK Healthcare Ltd) 22 ml en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2140121000001113 Rhinolast 140micrograms/dose nasal spray (Viatris UK Healthcare Ltd) 22 ml (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
29493301000001110 Rhinolast 140micrograms/actuation nasal spray (Viatris Pharmaceuticals Ltd) 22 ml (product) en Fully specified name Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module
29493401000001119 Rhinolast 140micrograms/actuation nasal spray (Viatris Pharmaceuticals Ltd) 22 ml en Synonym Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module
39129901000001119 Rhinolast 140micrograms/actuation nasal spray (Meda Pharmaceuticals Ltd) 22 ml en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
58719401000001119 Rhinolast 140micrograms/dose nasal spray (Meda Pharmaceuticals Ltd) 22 ml en Synonym Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Rhinolast 140micrograms/dose nasal spray (Viatris UK Healthcare Ltd) 22 ml Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Rhinolast 140micrograms/dose nasal spray (Viatris UK Healthcare Ltd) 22 ml Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Rhinolast 140micrograms/dose nasal spray (Viatris UK Healthcare Ltd) 22 ml Is a Azelastine 140micrograms/actuation nasal spray 22 ml true Inferred relationship Existential restriction modifier
Rhinolast 140micrograms/dose nasal spray (Viatris UK Healthcare Ltd) 22 ml Is pack of Rhinolast 140micrograms/dose nasal spray (Viatris UK Healthcare Ltd) false Inferred relationship Existential restriction modifier
Rhinolast 140micrograms/dose nasal spray (Viatris UK Healthcare Ltd) 22 ml Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Rhinolast 140micrograms/dose nasal spray (Viatris UK Healthcare Ltd) 22 ml Has active ingredient Azelastine hydrochloride false Inferred relationship Existential restriction modifier
Rhinolast 140micrograms/dose nasal spray (Viatris UK Healthcare Ltd) 22 ml Has excipient Edetate disodium false Inferred relationship Existential restriction modifier
Rhinolast 140micrograms/dose nasal spray (Viatris UK Healthcare Ltd) 22 ml Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Rhinolast 140micrograms/dose nasal spray (Viatris UK Healthcare Ltd) 22 ml Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Rhinolast 140micrograms/dose nasal spray (Viatris UK Healthcare Ltd) 22 ml VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Rhinolast 140micrograms/dose nasal spray (Viatris UK Healthcare Ltd) 22 ml VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Rhinolast 140micrograms/dose nasal spray (Viatris UK Healthcare Ltd) 22 ml Has manufactured dose form Spray dose form false Inferred relationship Existential restriction modifier
Rhinolast 140micrograms/dose nasal spray (Viatris UK Healthcare Ltd) 22 ml Has AMP Rhinolast 140micrograms/dose nasal spray (Viatris UK Healthcare Ltd) true Inferred relationship Existential restriction modifier
Rhinolast 140micrograms/dose nasal spray (Viatris UK Healthcare Ltd) 22 ml Has specific active ingredient Azelastine hydrochloride true Inferred relationship Existential restriction modifier
Rhinolast 140micrograms/dose nasal spray (Viatris UK Healthcare Ltd) 22 ml Has dispensed dose form Spray dose form true Inferred relationship Existential restriction modifier
Rhinolast 140micrograms/dose nasal spray (Viatris UK Healthcare Ltd) 22 ml Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start